Astera Labs (NASDAQ:ALAB) Shares Up 5.7% - Time to Buy?

Key Points

• The shares of **Astera Labs (NASDAQ:ALAB)** increased by **5.7%** during mid-day trading, reaching a last trading price of **$163.64**.
• Analysts have mixed ratings on Astera Labs, with **14 analysts** recommending a **Buy** rating and **9** suggesting **Hold**, while one firm set a price target of **$190.00**.
• Insider trading activities indicate significant selling, as the CFO and a Director sold a combined total of **125,000 shares**, demonstrating a noticeable decrease in their ownership percentages.

Shares of Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) traded up 5.7% during mid-day trading on Thursday . The stock traded as high as $166.33 and last traded at $163.64. 5,172,654 shares were traded during trading, a decline of 1% from the average session volume of 5,233,244 shares. The stock had previously closed at $154.85.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Weiss Ratings reissued a "hold (c-)" rating on shares of Astera Labs in a research report on Wednesday, October 8th. Zacks Research lowered Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 6th. Wall Street Zen raised Astera Labs from a "hold" rating to a "buy" rating in a research report on Saturday, October 18th. Cowen assumed coverage on Astera Labs in a research report on Tuesday, September 30th. They set a "hold" rating on the stock. Finally, CICC Research assumed coverage on Astera Labs in a research report on Friday, August 29th. They set an "outperform" rating and a $190.00 price target on the stock. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs currently has a consensus rating of "Moderate Buy" and an average target price of $162.06.

Astera Labs Stock Performance

The stock has a market capitalization of $27.20 billion, a P/E ratio of 292.21, a P/E/G ratio of 3.92 and a beta of 1.43. The stock has a 50 day moving average of $197.75 and a 200 day moving average of $129.89.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. The firm had revenue of $191.93 million during the quarter, compared to the consensus estimate of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm's revenue was up 149.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO Michael Truett Tate sold 100,000 shares of the stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $171.38, for a total value of $17,138,000.00. Following the completion of the transaction, the chief financial officer owned 518,996 shares of the company's stock, valued at approximately $88,945,534.48. This represents a 16.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Stefan A. Dyckerhoff sold 25,000 shares of the stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $173.42, for a total value of $4,335,500.00. Following the completion of the transaction, the director directly owned 99,154 shares of the company's stock, valued at approximately $17,195,286.68. The trade was a 20.14% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,092,997 shares of company stock valued at $192,231,120. Company insiders own 12.50% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of ALAB. Oliver Lagore Vanvalin Investment Group bought a new position in shares of Astera Labs in the second quarter worth $29,000. Bernard Wealth Management Corp. bought a new position in shares of Astera Labs in the second quarter worth $36,000. Clearstead Trust LLC lifted its holdings in shares of Astera Labs by 46,100.0% in the second quarter. Clearstead Trust LLC now owns 462 shares of the company's stock valued at $42,000 after buying an additional 461 shares during the period. Advisors Asset Management Inc. lifted its holdings in shares of Astera Labs by 68.6% in the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company's stock valued at $43,000 after buying an additional 194 shares during the period. Finally, Manchester Capital Management LLC lifted its holdings in shares of Astera Labs by 141.5% in the second quarter. Manchester Capital Management LLC now owns 483 shares of the company's stock valued at $44,000 after buying an additional 283 shares during the period. Institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.